In situ assessment of Mindin as a biomarker of podocyte lesions in diabetic nephropathy.
Martins ALMDS, Bernardes AB, Ferreira VA, Wanderley DC, Araújo SA, do Carmo Neto JR, da Silva CA, Lira RCP, Araújo LS, Dos Reis MA, et al. PLoS One. 2023; 18(5):e0284789. Epub 2023 May 2.